Scott E Nelson Selected Research

Scott E Nelson Research Topics

3	Neoplasms (Cancer) 01/2022 - 03/2006
3	Type 2 Diabetes Mellitus (MODY) 01/2011 - 06/2005
2	Inflammation (Inflammations) 01/2021 - 06/2005
2	Hypoglycemia (Reactive Hypoglycemia) 01/2011 - 05/2006
1	Carcinoma (Carcinomatosis) 01/2022
1	Leukemia 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Carcinogenesis 01/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Epstein-Barr Virus Infections 01/2021
1	Infections 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Diabetes Complications 10/2011
1	Diabetes Mellitus 01/2011
1	Weight Gain 05/2006
1	Atherosclerosis 06/2005

4	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2006
4	Insulin (Novolin)FDA Link 01/2011 - 06/2005
1	RON proteinIBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	SyndecansIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	Syndecan-2IBA 01/2022
1	lysophosphatidic acidIBA 01/2021
1	Phorbol EstersIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020
1	Blood Glucose (Blood Sugar)IBA 10/2011
1	Insulin Detemir (Levemir)FDA Link 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 05/2006
1	Amino Acids FDA Link 03/2006

3	Therapeutics 01/2022 - 06/2005
2	Glycemic Control 01/2011 - 05/2006